BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 12452515)

  • 1. Botulinum toxin: a dreaded toxin for use in human being.
    Ghosh B; Das SK
    J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of botulinum toxin.
    Wheeler AH
    Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxins in neurological disease.
    Comella CL; Pullman SL
    Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin: structure, mode of action and therapeutic use].
    Tatarkiewicz J
    Postepy Hig Med Dosw; 1994; 48(5):505-20. PubMed ID: 7638099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G
    Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm].
    Mezaki T; Kaji R; Kimura J; Osame M; Mizuno Y; Hirayama K; Maruyama S; Iwata M; Kanazawa I; Kinoshita M
    No To Shinkei; 1995 Aug; 47(8):749-54. PubMed ID: 7546919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin in the treatment of hemifacial spasm.
    Chong PN
    Singapore Med J; 1990 Oct; 31(5):469-71. PubMed ID: 2259946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of focal dystonia with botulinum toxin].
    Gjerstad L; Kerty E; Nyberg-Hansen R
    Tidsskr Nor Laegeforen; 1991 Sep; 111(21):2637-9. PubMed ID: 1948848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Applications of the botulinum A toxin].
    Zajácz M
    Orv Hetil; 2003 May; 144(18):837-42. PubMed ID: 12785236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of writer's cramp with botulinum toxin].
    Amthor KF; Skjelland M; Heier MS
    Tidsskr Nor Laegeforen; 1994 Jun; 114(16):1830-1. PubMed ID: 8079300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin: basic science and clinical uses in otolaryngology.
    Blitzer A; Sulica L
    Laryngoscope; 2001 Feb; 111(2):218-26. PubMed ID: 11210864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.